China Pharmaceutical Market Report 2009

Publication Date	January 2009
Publisher	Pacific Bridge Medical
Product Type	Report
Pages	36
ISBN Number	not applicable
Product Code	PBM00001

Buy this product or for assistance call +44 20 7060 7474

PRINT £305.00$500 | €338

FAX Order above formats by FAX

Summary

China's pharmaceutical market is not only a large, rising opportunity in itself - reaching an estimated $37 billion in 2008 and still growing at near 20% annually - in the near future, it will also join the world's biggest pharmaceutical markets. This makes it strategically crucial for Western pharmaceutical companies to succeed there. However, the Chinese drug market has unique characteristics which must be understood to make the China potential a reality.

This research report contains key information on multiple important topics of the Chinese pharmaceutical market, including market data, the role of government health insurance reimbursement, government price controls, institutional purchasing practices, differing characteristics and business strategies of domestic and foreign pharmaceutical companies, and more. It also includes three appendices: one on recent acquisitions, ventures, and partnerships in the Chinese drug industry; a list of all drugs which Chinese government health insurance will reimburse; and contact information for key Chinese drug agencies.

This report is 36 pages. The appendices are an additional 26 pages.

Fully updated for 2009.

Content

I. Introduction to China
II. Overview of China Pharmaceutical Market
- i. China Healthcare System
- ii. Growth in Healthcare Spending
- iii. Pharmaceutical Sales
III. Health Insurance in China
- i. Overview
- ii. Basic Medical Insurance
- iii. Other Public Health Insurance Systems
- iv. Private Health Insurance
IV. Drug Reimbursement System
- i. Mechanics of Drug Reimbursement
- ii. Drug Reimbursement List
- iii. Who Controls Revisions to Drug Reimbursement Lists
- iv. When Reimbursement is Important
- v. Strategies for Reimbursement List Entry
V. Price Determination
VI. Hospital Purchasing and Prescribing
- i. Hospital Tendering
- ii. Prescription Controls
VII. Foreign Pharmaceutical Companies in China
- i. Overview
- ii. Trends
VIII. Domestic Chinese Pharmaceutical Companies
- i. Overview
- ii. Domestic Pharmaceutical Companies' Changing Strategies
IX. Pharmaceutical Distribution in China
X. Predicted Trends
- i. Overview
- ii. Healthcare Providers
- iii. Healthcare Funding
- iv. Reimbursement System
- v. Price Determination
- vi. Regulatory Approvals
XI. Conclusion
Appendices:
- Appendix A: Recent Acquisitions, Ventures, and Partnerships in the Chinese Drug Industry
- Appendix B: National Reimbursement Drug List
- Appendix C: Key Drug Agencies in China

Delivery Details

PRINT/CD-ROM:despatched via by standard US mail for US order with delivery within 1to 5 days. Orders for Europe and ROW courier dispatch with delivery within 2 to 10 days.

Ask a question about this product

Need help finding the right product?